Hon.Non-Executive President CP

ABLE the face of Indian Biotechnology

[DPIIT India @DPIITGoI]

The Government has notified the Startup India Fund of Funds 2.0 (Startup India FoF 2.0) with a total corpus of ₹10,000 crore to mobilize venture and growth capital for the country’s startup ecosystem.

#StartupIndia #Innovation

Read More: https://t.co/ncYXROg1m6

[Hon.Non-Executive President CP @AbleCouncil]

https://t.co/KK4eibPRk8

[President@ABLEIndia @able_president]

India #BioEconomy report 2026 prepared by #ABLE was released by Hon. Minister @DrJitendraSingh . The 2025 #BioEconomy value is $195.3 billion, @18% growth contributing to 4.8% GDP. #BioIndustrial - 46% and #BioPharma - 33% are the major contributors.
@kiranshaw @Muralipm

[Kiran Mazumdar-Shaw @kiranshaw]

I commend Govt of Karnataka and CM @siddaramaiah for a forward looking Budget 2026. I appreciate the significant budgetary allocation for Bengaluru Infrastructure, the booster dose for Biotech in advancing genomics & precision medicine, CHG upgrade, AI CoE at IBAB & C-CAMP and the significant increase in investment in AI led Medtech & Robotics and LEAP K-Combinator accelerator. I also welcome the focus on women focused development including women entrepreneurs. @DKShivakumar @PriyankKharge

[ABLE @able_indiabio]

🚀 𝐉𝐨𝐢𝐧 𝐔𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐑𝐨𝐮𝐧𝐝𝐭𝐚𝐛𝐥𝐞 ‘𝐂𝐨𝐧𝐯𝐞𝐫𝐠𝐞𝐧𝐜𝐞 𝐨𝐟 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐚𝐧𝐝 𝐁𝐢𝐭𝐬’ 𝐚𝐭 𝐀𝐁𝐋𝐄 𝐁𝐢𝐨𝐄𝐜𝐨𝐧𝐨𝐦𝐲 𝐂𝐨𝐧𝐜𝐥𝐚𝐯𝐞 2026!
📅 24 𝐅𝐞𝐛𝐫𝐮𝐚𝐫𝐲 2026 📍 𝐓𝐚𝐣 𝐌𝐆 𝐑𝐨𝐚𝐝, 𝐁𝐞𝐧𝐠𝐚𝐥𝐮𝐫𝐮

We are in the BioDigital Convergence era, where AI is transforming biotech research—accelerating drug discovery, repurposing compounds, and identifying genomic markers for disease prevention. In agriculture, AI enables climate-resilient crops and enhances process efficiencies. It also supports synthetic alternatives to crop-based products, meeting rising global demands for quality, sustainability, and performance.

🎤 𝐌𝐨𝐝𝐞𝐫𝐚𝐭𝐨𝐫:
🔹 𝐌𝐫. 𝐍𝐚𝐫𝐚𝐲𝐚𝐧𝐚𝐧 𝐒𝐮𝐫𝐞𝐬𝐡, Advisor, ABLE - Association of Biotechnology Led Enterprises

👥 𝐒𝐩𝐞𝐚𝐤𝐞𝐫𝐬:
🔹 𝐃𝐫. 𝐕𝐢𝐣𝐚𝐲 𝐂𝐡𝐚𝐧𝐝𝐫𝐮, Founder Director, Strand Life Sciences & CrisprBits Private Limited
🔹 𝐃𝐫. 𝐍𝐚𝐫𝐚𝐲𝐚𝐧𝐚𝐧 𝐊𝐨𝐭𝐭𝐚𝐫𝐚𝐦, Founder & Managing Director, Sthayika Seeds Pvt. Ltd.
🔹 𝐌𝐫. 𝐒𝐡𝐫𝐢𝐤𝐮𝐦𝐚𝐫 𝐒𝐮𝐫𝐲𝐚𝐧𝐚𝐫𝐚𝐲𝐚𝐧, CMD, Sea6 Energy Pvt Ltd.
🔹 𝐃𝐫. 𝐏 𝐌 𝐌𝐮𝐫𝐚𝐥𝐢, President, ABLE Council of Presidents & CMD, Jananom Private Limited

🧬 Join this high-impact roundtable as industry leaders explore how the convergence of biology and digital intelligence is reshaping healthcare, agriculture, and the future of India’s bioeconomy.

[Hon.Non-Executive President CP @AbleCouncil]

ABLE will be looking forward to the budget of the Hon Finance Minister. Hope it paves the way for private investments to come into R&D which will drive innovation. @kiranshaw . Also hope startups have lesser compliance burden. Deep tech industry needs a bjg boost.

[Hon.Non-Executive President CP @AbleCouncil]

@kiranshaw

[Panchapagesa Murali @Muralipm]

The new BIO E3 policy will propel and spurn innovation in Synthetic Biology led biomanufacturing. @DrJitendraSingh @DBTIndia @BIRAC_2012

[Hon.Non-Executive President CP @AbleCouncil]

Nice to see bright youngsters at the Voice for BT programme.@able_president

[Hon.Non-Executive President CP @AbleCouncil]

Proud to be at #Sastrauniversity for the 13th edition of Voice for BT. @SastraUniv.

[Hon.Non-Executive President CP @AbleCouncil]

@able_president @kiranshaw

[Panchapagesa Murali @Muralipm]

Bio Taiwan Asia does a great annual show. Happy to serve on their International Committee and be part of the Regional collaboration.

[DBT-BIRAC @BIRAC_2012]

Mr. G. S. Krishnan, President of #ABLE, underscores the immense potential of India’s bioeconomy, driven by advancements in agriculture, healthcare, and industrial biotechnology.
#BioeconomyGrowth #InnovationForImpact #BiotechForIndia #SustainableFuture

[ABLE @able_indiabio]

Dr. P M Murali, President, ABLE Council of Presidents participated in #China-#India Closed-Door Meeting at #BIOCHINA 2025 - a strategic platform for fostering biopharma collaboration, driving innovation, and unlocking new opportunities between the two nation.🌏
@Muralipm

[Department of Biotechnology @DBTIndia]

During the Biotech Session at Advantage Assam 2.0, Dr. Alka Sharma emphasized Assam’s unique potential in biomanufacturing & bio-based industries. With its rich biodiversity & strategic location, Assam can drive India's BioE3 vision through fostering innovation in functional foods, precision biotherapeutics & sustainable biotech solutions. #AdvantageAssam2.0 #Biotech
@DrJitendraSingh @rajesh_gokhale

[Department of Biotechnology @DBTIndia]

The Biotech Session at Advantage Assam 2.0 in Guwahati brought together experts, industry leaders & policymakers to discuss Assam’s potential in biomanufacturing & sustainable biotechnology. Co-chaired by Dr. Alka Sharma, Senior Adviser, DBT, the session highlighted innovation, investment & ecosystem growth in Assam’s biotechnology sector. #BioE3 #AdvantageAssam2.0

@DrJitendraSingh @rajesh_gokhale

[Hon.Non-Executive President CP @AbleCouncil]

@Muralipm

[DBT-BIRAC @BIRAC_2012]

The #BioE3 (Biotechnology for Economy, Environment & Employment) Policy for Fostering High-Performance Bio-manufacturing has been officially approved by the Union Cabinet.

[Hon.Non-Executive President CP @AbleCouncil]

ABLE conclave. What a lot of exciting speakers and sessions. A programme very well conceived. Thanks to Hon. Minister Kharge Ji and Kiran for setting the stage.@able_indiabio @able_president @kiranshaw @PriyankKharge @Muralipm

[Hon.Non-Executive President CP @AbleCouncil]

@able_indiabio @able_president @Muralipm @balu_sbc @ITBTGoK @Ktech_biotech @DBTIndia @BIRAC_2012 @Startup_Kar Looking forward.

[Hon.Non-Executive President CP @AbleCouncil]

GS Krishnan of ABLE addressing the audience in the Blue Economy conference in Bhubaneswar. @able_indiabio @able_president

[Hon.Non-Executive President CP @AbleCouncil]

@able_indiabio @able_president . Contact to know more in how to set up your startup in UAE.

[ABLE @able_indiabio]

Join us on Nov 19th at #BengaluruTechSummit for Biotech & Healthtech sessions curated by ABLE! 🌍Don’t miss “Unlocking the Bioeconomy Potential,” where global leaders will explore how biotech is driving sustainability, market growth & economic innovation.